Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke

European Journal of Clinical Pharmacology

Volumn 55, Issue 11-12, 2000, Pages 867-872

  Hoke, J F ^a   Dyker, A G ^b   Barnaby, R J ^c   Lees, K R ^b  

^a GLAXOSMITHKLINE   (United States)

^b WESTERN INFIRMARY   (United Kingdom)

^c GSK   (Italy)

Author keywords

Acute stroke; Gavestinel; Pharmacokinetics

Indexed keywords

BILIRUBIN; GAVESTINEL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEADY STATE; STROKE;

EID: 0034079184     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050709     Document Type: Article

References (9)

1. Doble A (1999) The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 81: 163-221
2. Danysz W, Parsons CG (1998) Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 50: 597-664
3. Bordi F, Pietra C, Ziviani L, Reggiani A (1997) The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct volume in the MCAo model of focal ischemia in the rat. Exp Neurol 145: 425-433
4. Dyker AG, Lees KR (1999) The safety and tolerability of GV150526 (a glycine site antagonist at the N-methyl-D-aspartate receptor) in patients with acute stroke. Stroke 30: 986-992
5. Capelle P, Dhumeaux D, Mora M, Feldman G, Berthelot P (1972) Effect of rifampicin on liver function in man. Gut 13: 366-371
6. List AF, Spier C, Greer J, Wolff S, Hutter J, Dorr R, Salmon S, Futscher B, Baler M, Dalton W (1993) Phase I/II trial of cyclosporin as a chemotherapy-resistance modifier in acute leukemia. J Clin Oncol 11: 1652-1660
7. Rowland M, Tozer TN (1995) Clinical pharmacokinetics - concepts and applications, 3rd edn. Williams and Wilkins, Philadelphia
8. Faed EM (1984) Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab Rev 15: 1213-1249
9. Gosland MP, Brophy NA, Duran GE, Yahanda AM, Adler KM, Hardy RI, Halsey J, Sikic BI (1991) Bilirubin: a physiological substrate for multidrug transporter. Proc Am Assoc Cancer Res 32: 426